Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.075 USD | -7.10% |
|
-4.39% | +69.44% |
06-10 | Pyxis Oncology, Inc. Appoints Michael A. Metzger to Its Board of Directors | CI |
05-14 | Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.44% | 195M | |
+15.37% | 121B | |
+19.30% | 113B | |
+17.47% | 26.02B | |
-25.32% | 19.39B | |
-19.51% | 15.91B | |
-19.54% | 15.09B | |
-46.87% | 15.06B | |
+61.47% | 14.93B | |
+5.68% | 13.85B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- BTIG Initiates Pyxis Oncology With Buy Rating, $8 Price Target